AB Biosciences
Private Company
Funding information not available
Overview
AB Biosciences is a specialized antibody engineering and production company serving the global research and drug discovery community. Founded in 2007 and based in San Diego, it focuses on creating niche antibody reagents and tools that are not widely available from larger suppliers. Its business model appears to be service and product-based, catering primarily to academic, biotech, and pharmaceutical researchers. The company emphasizes next-day shipping, indicating a commercial, revenue-generating operation with a direct-to-consumer e-commerce platform.
Technology Platform
Antibody engineering and production platform for creating niche and custom antibody molecules, enabling rapid turnaround for research and drug discovery applications.
Opportunities
Risk Factors
Competitive Landscape
AB Biosciences competes in a fragmented market that includes large catalog reagent suppliers (e.g., Thermo Fisher, Abcam), specialized antibody boutiques, and CROs offering discovery services. Its differentiation lies in focusing on niche, hard-to-find antibodies and emphasizing speed and customization, areas often underserved by larger players. It must continually innovate to stay ahead of both broad and niche competitors.